Foundry Earnings Quality (Accruals) Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1NFLX | NETFLIX INC | Communication Services | $290.47B | 23.36% |
2SNOW | SNOWFLAKE INC | Technology | $93.20B | 7.49% |
3TTWO | TAKE TWO INTERACTIVE SOFTWARE INC | Communication Services | $43.94B | 3.53% |
4CRWV | COREWEAVE INC | Technology | $39.94B | 3.21% |
5RVMD | REVOLUTION MEDICINES INC | Healthcare | $39.58B | 3.18% |
6WDAY | WORKDAY INC | Technology | $35.76B | 2.88% |
7DXCM | DEXCOM INC | Healthcare | $29.58B | 2.38% |
8ECHO | ECHO GLOBAL LOGISTICS INC | Industrials | $26.66B | 2.14% |
9CPRT | COPART INC | Industrials | $25.56B | 2.06% |
10VRSN | VERISIGN INC | Technology | $25.27B | 2.03% |
11MDB | MONGODB INC | Technology | $25.12B | 2.02% |
12MRNA | MODERNA INC | Healthcare | $24.53B | 1.97% |
13CPAY | CORPAY INC | Technology | $23.91B | 1.92% |
14UTHR | UNITED THERAPEUTICS CORP | Healthcare | $22.74B | 1.83% |
15RIVN | RIVIAN AUTOMOTIVE INC | Consumer Cyclical | $22.00B | 1.77% |
16IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Basic Materials | $19.96B | 1.61% |
17CRCL | CIRCLE INTERNET GROUP INC | Financial Services | $15.03B | 1.21% |
18ONTO | ONTO INNOVATION INC | Technology | $13.92B | 1.12% |
19BTSG | BRIGHTSPRING HEALTH SERVICES INC | Healthcare | $13.71B | 1.10% |
20APA | APA CORP | Energy | $12.45B | 1.00% |
21BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | $11.52B | 0.93% |
22HUBS | HUBSPOT INC | Technology | $11.49B | 0.92% |
23CYTK | CYTOKINETICS INC | Healthcare | $9.98B | 0.80% |
24HALO | HALOZYME THERAPEUTICS INC | Healthcare | $9.23B | 0.74% |
25WULF | TERAWULF INC | Financial Services | $9.00B | 0.72% |
26OSCR | OSCAR HEALTH INC | Healthcare | $8.77B | 0.71% |
27ZG | ZILLOW GROUP INC | Communication Services | $7.71B | 0.62% |
28SM | SM ENERGY CO | Energy | $7.51B | 0.60% |
29MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | $7.25B | 0.58% |
30CIFR | CIPHER DIGITAL INC | Financial Services | $7.18B | 0.58% |
31HNGE | HINGE HEALTH INC | Healthcare | $6.74B | 0.54% |
32IDCC | INTERDIGITAL INC | Communication Services | $6.73B | 0.54% |
33CORZ | CORE SCIENTIFIC INC | Technology | $6.66B | 0.54% |
34BYD | BOYD GAMING CORP | Consumer Cyclical | $6.52B | 0.52% |
35LUMN | LUMEN TECHNOLOGIES INC | Communication Services | $6.47B | 0.52% |
36SRRK | SCHOLAR ROCK HOLDING CORP | Healthcare | $6.33B | 0.51% |
37LYFT | LYFT INC | Technology | $5.89B | 0.47% |
38ENPH | ENPHASE ENERGY INC | Technology | $5.48B | 0.44% |
39HRB | H&R BLOCK INC | Consumer Cyclical | $5.33B | 0.43% |
40TVTX | TRAVERE THERAPEUTICS INC | Healthcare | $5.27B | 0.42% |
41LAUR | LAUREATE EDUCATION INC | Consumer Defensive | $5.10B | 0.41% |
42MGY | MAGNOLIA OIL & GAS CORP | Energy | $5.04B | 0.41% |
43DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | $4.83B | 0.39% |
44CRC | CALIFORNIA RESOURCES CORP | Energy | $4.69B | 0.38% |
45LBRDA | LIBERTY BROADBAND CORP | Communication Services | $4.43B | 0.36% |
46VKTX | VIKING THERAPEUTICS INC | Healthcare | $4.31B | 0.35% |
47ALHC | ALIGNMENT HEALTHCARE INC | Healthcare | $4.26B | 0.34% |
48PI | IMPINJ INC | Technology | $4.21B | 0.34% |
49CNR | CORE NATURAL RESOURCES INC | Basic Materials | $4.18B | 0.34% |
50MARA | MARA HOLDINGS INC | Financial Services | $4.08B | 0.33% |
51LION | LIONSGATE STUDIOS CORP | Communication Services | $4.03B | 0.32% |
52DOCS | DOXIMITY INC | Healthcare | $3.94B | 0.32% |
53POWI | POWER INTEGRATIONS INC | Technology | $3.93B | 0.32% |
54TDS | TELEPHONE & DATA SYSTEMS INC | Communication Services | $3.90B | 0.31% |
55DK | DELEK US HOLDINGS INC | Energy | $3.88B | 0.31% |
56RLAY | RELAY THERAPEUTICS INC | Healthcare | $3.81B | 0.31% |
57PTEN | PATTERSON UTI ENERGY INC | Energy | $3.80B | 0.31% |
58DNLI | DENALI THERAPEUTICS INC | Healthcare | $3.70B | 0.30% |
59MSGE | MADISON SQUARE GARDEN ENTERTAINMENT CORP | Consumer Cyclical | $3.56B | 0.29% |
60CRGY | CRESCENT ENERGY CO | Energy | $3.55B | 0.29% |
61RNG | RINGCENTRAL INC | Technology | $3.46B | 0.28% |
62RCUS | ARCUS BIOSCIENCES INC | Healthcare | $3.44B | 0.28% |
63CLSK | CLEANSPARK INC | Financial Services | $3.34B | 0.27% |
64SEDG | SOLAREDGE TECHNOLOGIES INC | Technology | $3.25B | 0.26% |
65AD | ARRAY DIGITAL INFRASTRUCTURE INC | Communication Services | $3.02B | 0.24% |
66FRSH | FRESHWORKS INC | Technology | $3.01B | 0.24% |
67BRZE | BRAZE INC | Technology | $2.98B | 0.24% |
68RARE | ULTRAGENYX PHARMACEUTICAL INC | Healthcare | $2.88B | 0.23% |
69LCID | LUCID GROUP INC | Consumer Cyclical | $2.87B | 0.23% |
70SUPN | SUPERNUS PHARMACEUTICALS INC | Healthcare | $2.79B | 0.22% |
71CLDX | CELLDEX THERAPEUTICS INC | Healthcare | $2.77B | 0.22% |
72VERA | VERA THERAPEUTICS INC | Healthcare | $2.76B | 0.22% |
73VISN | VISTANCE NETWORKS INC | Technology | $2.74B | 0.22% |
74NVTS | NAVITAS SEMICONDUCTOR CORP | Technology | $2.68B | 0.22% |
75KOD | KODIAK SCIENCES INC | Healthcare | $2.67B | 0.21% |
76PGNY | PROGYNY INC | Healthcare | $2.50B | 0.20% |
77TALO | TALOS ENERGY INC | Energy | $2.49B | 0.20% |
78BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | $2.36B | 0.19% |
79AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | $2.36B | 0.19% |
80BHVN | BIOHAVEN LTD | Healthcare | $2.32B | 0.19% |
81NOG | NORTHERN OIL & GAS INC | Energy | $2.24B | 0.18% |
82IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | $2.23B | 0.18% |
83SION | SIONNA THERAPEUTICS INC | Healthcare | $2.23B | 0.18% |
84AGL | AGILON HEALTH INC | Healthcare | $2.17B | 0.17% |
85VERX | VERTEX INC | Technology | $2.07B | 0.17% |
86CDNA | CAREDX INC | Healthcare | $2.05B | 0.17% |
87SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | $2.02B | 0.16% |
88AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | $1.97B | 0.16% |
89CPRI | CAPRI HOLDINGS LTD | Consumer Cyclical | $1.89B | 0.15% |
90SAM | BOSTON BEER CO INC | Consumer Defensive | $1.86B | 0.15% |
91MQ | MARQETA INC | Technology | $1.85B | 0.15% |
92NVCR | NOVOCURE LTD | Healthcare | $1.84B | 0.15% |
93LIND | LINDBLAD EXPEDITIONS HOLDINGS INC | Industrials | $1.81B | 0.15% |
94ASAN | ASANA INC | Technology | $1.77B | 0.14% |
95ZYME | ZYMEWORKS INC | Healthcare | $1.77B | 0.14% |
96TDOC | TELADOC HEALTH INC | Healthcare | $1.70B | 0.14% |
97ANAB | ANAPTYSBIO INC | Healthcare | $1.69B | 0.14% |
98FTRE | FORTREA HOLDINGS INC | Healthcare | $1.68B | 0.14% |
99CMPS | COMPASS PATHWAYS PLC | Healthcare | $1.67B | 0.13% |
100TH | TARGET HOSPITALITY CORP | Industrials | $1.64B | 0.13% |
101TE | T1 ENERGY INC | Industrials | $1.63B | 0.13% |
102PUMP | PROPETRO HOLDING CORP | Energy | $1.59B | 0.13% |
103VIR | VIR BIOTECHNOLOGY INC | Healthcare | $1.59B | 0.13% |
104NTLA | INTELLIA THERAPEUTICS INC | Healthcare | $1.59B | 0.13% |
105BRUN | BOOST RUN INC | Technology | $1.50B | 0.12% |
106AHCO | ADAPTHEALTH CORP | Healthcare | $1.49B | 0.12% |
107TRS | TRIMAS CORP | Consumer Cyclical | $1.46B | 0.12% |
108MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | $1.45B | 0.12% |
109ARLO | ARLO TECHNOLOGIES INC | Basic Materials | $1.45B | 0.12% |
110YELP | YELP INC | Communication Services | $1.44B | 0.12% |
111AIP | ARTERIS INC | Technology | $1.43B | 0.12% |
112BJRI | BJS RESTAURANTS INC | Consumer Cyclical | $1.42B | 0.11% |
113CXM | SPRINKLR INC | Technology | $1.37B | 0.11% |
114AMN | AMN HEALTHCARE SERVICES INC | Healthcare | $1.36B | 0.11% |
115REAL | THEREALREAL INC | Consumer Cyclical | $1.35B | 0.11% |
116BW | BABCOCK & WILCOX ENTERPRISES INC | Industrials | $1.35B | 0.11% |
117DMLP | DORCHESTER MINERALS LP | Energy | $1.31B | 0.11% |
118FCEL | FUELCELL ENERGY INC | Industrials | $1.25B | 0.10% |
119NBR | NABORS INDUSTRIES LTD | Energy | $1.24B | 0.10% |
120HTLD | HEARTLAND EXPRESS INC | Industrials | $1.19B | 0.10% |
121MMI | MARCUS & MILLICHAP INC | Real Estate | $1.18B | 0.09% |
122MGTX | MEIRAGTX HOLDINGS PLC | Healthcare | $1.15B | 0.09% |
123EYPT | EYEPOINT INC | Healthcare | $1.12B | 0.09% |
124EVLV | EVOLV TECHNOLOGIES HOLDINGS INC | Industrials | $1.02B | 0.08% |
125PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.01B | 0.08% |
126FBRX | FORTE BIOSCIENCES INC | Healthcare | $1.00B | 0.08% |
127EVC | ENTRAVISION COMMUNICATIONS CORP | Communication Services | $984M | 0.08% |
128KURA | KURA ONCOLOGY INC | Healthcare | $964M | 0.08% |
129ANNX | ANNEXON INC | Healthcare | $950M | 0.08% |
130HPK | HIGHPEAK ENERGY INC | Energy | $931M | 0.07% |
131GLIBA | GCI LIBERTY INC | Communication Services | $881M | 0.07% |
132REPL | REPLIMUNE GROUP INC | Healthcare | $859M | 0.07% |
133SG | SWEETGREEN INC | Consumer Cyclical | $841M | 0.07% |
134CYRX | CRYOPORT INC | Industrials | $832M | 0.07% |
135CODI | COMPASS DIVERSIFIED HOLDINGS | Industrials | $777M | 0.06% |
136BBNX | BETA BIONICS INC | Healthcare | $771M | 0.06% |
137REPX | RILEY EXPLORATION PERMIAN INC | Energy | $759M | 0.06% |
138IBTA | IBOTTA INC | Technology | $734M | 0.06% |
139AURA | AURA BIOSCIENCES INC | Healthcare | $723M | 0.06% |
140TXO | TXO PARTNERS LP | Energy | $707M | 0.06% |
141SPRY | ARS PHARMACEUTICALS INC | Healthcare | $695M | 0.06% |
142PKE | PARK AEROSPACE CORP | Industrials | $677M | 0.05% |
143SWBI | SMITH & WESSON BRANDS INC | Industrials | $665M | 0.05% |
144VTS | VITESSE ENERGY INC | Energy | $664M | 0.05% |
145CNNE | CANNAE HOLDINGS INC | Consumer Cyclical | $657M | 0.05% |
146ACHV | ACHIEVE LIFE SCIENCES INC | Healthcare | $644M | 0.05% |
147PUBM | PUBMATIC INC | Technology | $591M | 0.05% |
148NGNE | NEUROGENE INC | Healthcare | $590M | 0.05% |
149ETD | ETHAN ALLEN INTERIORS INC | Consumer Cyclical | $580M | 0.05% |
150WEAV | WEAVE COMMUNICATIONS INC | Healthcare | $575M | 0.05% |
151MLR | MILLER INDUSTRIES INC | Consumer Cyclical | $566M | 0.05% |
152EGY | VAALCO ENERGY INC | Energy | $553M | 0.04% |
153WNC | WABASH NATIONAL CORP | Industrials | $547M | 0.04% |
154CTRN | CITI TRENDS INC | Consumer Cyclical | $535M | 0.04% |
155ARVN | ARVINAS INC | Healthcare | $517M | 0.04% |
156SPIR | SPIRE GLOBAL INC | Industrials | $488M | 0.04% |
157PAYS | PAYSIGN INC | Technology | $478M | 0.04% |
158VMD | VIEMED HEALTHCARE INC | Healthcare | $466M | 0.04% |
159AMCX | AMC GLOBAL MEDIA INC | Communication Services | $461M | 0.04% |
160STRZ | STARZ ENTERTAINMENT CORP | Communication Services | $450M | 0.04% |
161SRTA | STRATA CRITICAL MEDICAL INC | Industrials | $446M | 0.04% |
162BNED | BARNES & NOBLE EDUCATION INC | Consumer Cyclical | $437M | 0.04% |
163ASPN | ASPEN AEROGELS INC | Basic Materials | $425M | 0.03% |
164MCFT | MASTERCRAFT BOAT HOLDINGS INC | Consumer Cyclical | $407M | 0.03% |
165ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | $400M | 0.03% |
166EBS | EMERGENT BIOSOLUTIONS INC | Healthcare | $394M | 0.03% |
167UPB | UPSTREAM BIO INC | Healthcare | $382M | 0.03% |
168ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | $364M | 0.03% |
169MTRX | MATRIX SERVICE CO | Industrials | $342M | 0.03% |
170RTAC | RENATUS TACTICAL ACQUISITION CORP I | Industrials | $329M | 0.03% |
171VNDA | VANDA PHARMACEUTICALS INC | Healthcare | $327M | 0.03% |
172FNKO | FUNKO INC | Consumer Cyclical | $326M | 0.03% |
173PAMT | PAMT CORP | Industrials | $311M | 0.02% |
174FHTX | FOGHORN THERAPEUTICS INC | Healthcare | $305M | 0.02% |
175ALCO | ALICO INC | Consumer Defensive | $304M | 0.02% |
176PNRG | PRIMEENERGY RESOURCES CORP | Energy | $302M | 0.02% |
177TKNO | ALPHA TEKNOVA INC | Healthcare | $291M | 0.02% |
178UCFI | CN HEALTHY FOOD TECH GROUP CORP | Consumer Defensive | $288M | 0.02% |
179TRDA | ENTRADA THERAPEUTICS INC | Healthcare | $268M | 0.02% |
180ALMU | AELUMA INC | Technology | $267M | 0.02% |
181LOVE | LOVESAC CO | Consumer Cyclical | $267M | 0.02% |
182SVCO | SILVACO GROUP INC | Technology | $260M | 0.02% |
183VNME | VENDOME ACQUISITION CORP I | Industrials | $254M | 0.02% |
184ARTV | ARTIVA BIOTHERAPEUTICS INC | Healthcare | $241M | 0.02% |
185GLSI | GREENWICH LIFESCIENCES INC | Healthcare | $240M | 0.02% |
186QUIK | QUICKLOGIC CORP | Technology | $237M | 0.02% |
187GTE | GRAN TIERRA ENERGY INC | Energy | $233M | 0.02% |
188KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | $216M | 0.02% |
189ALTG | ALTA EQUIPMENT GROUP INC | Industrials | $208M | 0.02% |
190PAL | PROFICIENT AUTO LOGISTICS INC | Industrials | $197M | 0.02% |
191SRI | STONERIDGE INC | Consumer Cyclical | $197M | 0.02% |
192COOK | TRAEGER INC | Consumer Cyclical | $193M | 0.02% |
193EAF | GRAFTECH INTERNATIONAL LTD | Industrials | $181M | 0.01% |
194INFU | INFUSYSTEM HOLDINGS INC | Healthcare | $180M | 0.01% |
195KVHI | KVH INDUSTRIES INC | Technology | $178M | 0.01% |
196INSE | INSPIRED ENTERTAINMENT INC | Consumer Cyclical | $174M | 0.01% |
197KORE | KORE GROUP HOLDINGS INC | Communication Services | $163M | 0.01% |
198PED | PEDEVCO CORP | Energy | $161M | 0.01% |
199RCEL | AVITA MEDICAL INC | Healthcare | $157M | 0.01% |
200HOFT | HOOKER FURNISHINGS CORP | Consumer Cyclical | $152M | 0.01% |
201CHPT | CHARGEPOINT HOLDINGS INC | Consumer Cyclical | $146M | 0.01% |
202ACNT | ASCENT INDUSTRIES CO | Basic Materials | $138M | 0.01% |
203DMRC | DIGIMARC CORP | Technology | $133M | 0.01% |
204AARD | AARDVARK THERAPEUTICS INC | Healthcare | $128M | 0.01% |
205VATE | INNOVATE CORP | Industrials | $123M | 0.01% |
206INSG | INSEEGO CORP | Technology | $122M | 0.01% |
207UFI | UNIFI INC | Consumer Cyclical | $118M | 0.01% |
208TCX | TUCOWS INC | Technology | $114M | 0.01% |
209SSTI | SOUNDTHINKING INC | Technology | $111M | 0.01% |
210TRT | TRIO-TECH INTERNATIONAL | Technology | $103M | 0.01% |
211CHRN | CHRONOSCALE CORP | Industrials | $94M | 0.01% |
212GEOS | GEOSPACE TECHNOLOGIES CORP | Energy | $88M | 0.01% |
213RLYB | RALLYBIO CORP | Healthcare | $87M | 0.01% |
214AEYE | AUDIOEYE INC | Technology | $82M | 0.01% |
215PIII | P3 HEALTH PARTNERS INC | Healthcare | $78M | 0.01% |
216ACET | ADICET BIO INC | Healthcare | $76M | 0.01% |
217SCLX | SCILEX HOLDING CO | Healthcare | $72M | 0.01% |
218BGSF | BGSF INC | Industrials | $65M | 0.01% |
219BRID | BRIDGFORD FOODS CORP | Consumer Defensive | $59M | 0.00% |
220SKIL | SKILLSOFT CORP | Consumer Defensive | $58M | 0.00% |
221LNZA | LANZATECH GLOBAL INC | Industrials | $56M | 0.00% |
222STEM | STEM INC | Technology | $56M | 0.00% |
223EXOZ | EXOZYMES INC | Healthcare | $51M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $1.24T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 88% toward Large, 64% toward Growth. +20% unclassified (44 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 223 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual28.7%Margin-3.7%Days required to liquidate the largest position at 20% of one day's dollar volume.
Required<= 7.0 daysActualunboundedMargin—
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 223 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators differ materially in value but agree on the verdict. Historical and Gaussian fund VaR differ by 33%; both still land on the same side of the 2x limit.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
There is no “before” to compare against — the predictor was already public when our data begins, so every month shown is out-of-sample relative to the original study.
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | -4.2% | -19.8% |
| 3 yearsp.a. | 15.7% | -17.9% |
| 5 yearsp.a. | 11.2% | -3.4% |
| 10 yearsp.a. | 15.0% | -4.6% |
| Since inceptionp.a. | 7.9% | -4.8% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | -1.1% | -8.3% |
| 2025 | 8.4% | -25.5% |
| 2024 | 31.4% | -28.4% |
| 2023 | 69.2% | 54.2% |
| 2022 | -32.6% | 13.8% |
| 2021 | 25.9% | -0.2% |
| 2020 | 26.2% | -26.9% |
| 2019 | 22.9% | -2.0% |
| 2018 | -1.9% | 5.1% |
| 2017 | 25.2% | -7.2% |
| 2016 | 19.7% | 9.5% |
| 2015 | 11.4% | 7.0% |
| 2014 | 6.4% | -8.4% |
| 2013 | 44.6% | -5.2% |
| 2012 | 27.2% | 27.1% |
| 2011 | -4.6% | -4.0% |
| 2010 | 22.7% | 10.6% |
| 2009 | 58.2% | -5.9% |
| 2008 | -39.0% | 7.3% |
| 2007 | 8.3% | -21.2% |
| 2006 | 12.3% | -7.5% |
| 2005 | 3.8% | -10.4% |
| 2004 | 13.9% | 5.8% |
| 2003 | 63.3% | 31.7% |
| 2002 | -49.0% | -30.5% |
| 2001 | -24.6% | -17.3% |
| 2000 | -37.0% | -12.2% |
| 1999 | 25.4% | -32.5% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry Earnings Quality (Accruals) Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a Earnings Quality (Accruals) signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.